4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001650664-25-000162
CEO sold 5,603 shares at $2.15 ($12,064)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-03 | Sale : show line 1 in the form 10b5-1 | −5,603 | $2.15 | $12,064 | 269,087 | D |
| Open-market sales · 5,603 sh · avg $2.15 · $12,064 | ||||||
Loading xslF345X05/wk-form4_1764884318.xml…